◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

昆药集团

昆药集团
Loading...
Price History
Market Data
Market Cap8.9B
Market Cap (USD)$1.2B
P/E Ratio-
P/B Ratio-
EPS0.46
Dividend Yield-
D/E Ratio0.70
Current Ratio2.02
Market SegmentMain Board
CurrencyCNY
Business Overview

KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotics, immunosuppressive, oral products, injections and others. The company's brands such as Luotai, Tianxuanqing, Artemedine, Artem and Arco. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People's Republic of China.

证监会行业分类 C27医药制造业 SSE
Key Financial Metrics
6.6B
Revenue
419.0M
Net Income
0.46
EPS (Diluted)
198.4M
Free Cash Flow
Profitability
Gross Margin -
Operating Margin 6.8%
Net Profit Margin 6.4%
EBITDA 449.0M
Returns & Efficiency
Return on Assets (ROA) 3.6%
Return on Equity (ROE) 6.0%
Dividend Yield -
EPS 0.46
Financial Health
Total Assets 11.8B
Total Debt 4.8B
Debt to Equity 0.70x
Current Ratio 2.02
Company Info
IndustryC27医药制造业
Market SegmentMain Board
CurrencyCNY
Fiscal Year2025
Peers
2.7T
P/E: 7.6
2.5T
P/E: 7.2
2.4T
P/E: 8.7
CNOOC LIMITED
600938
2.0T
P/E: 16.2
1.9T
P/E: 25.6
1.8T
P/E: 20.1
1.8T
P/E: 7.3
1.2T
P/E: 6.9
Stock Chart
Open Full Chart View

Full charting with technical indicators, candlestick, line charts, and more.

Company Profile
General Information
Company Name昆药集团
Ticker600422
ExchangeSSE
Sector证监会行业分类
IndustryC27医药制造业
Market SegmentMain Board
Fiscal Year2025
CurrencyCNY
Financial Summary
Market Cap8.9B
Market Cap (USD)$1.2B
Revenue6.6B
Net Income419.0M
P/E Ratio-
EPS0.46
Net Margin6.4%
ROE6.0%
Dividend Yield-
Description

KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotics, immunosuppressive, oral products, injections and others. The company's brands such as Luotai, Tianxuanqing, Artemedine, Artem and Arco. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People's Republic of China.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...